Andrew Tri Van Ho
Papers
1
Total Citations
3
H-Index
1
About
Andrew Tri Van Ho is a pioneering figure in radiation oncology, best known for his foundational work in stereotactic body radiation therapy (SBRT) for lung tumors. His key research areas include stereotactic radiosurgery, dose escalation for inoperable lung cancers, and the development of non-invasive ablative radiotherapy techniques. Ho’s most notable contribution is his landmark phase I dose escalation trial, "Single fraction stereotactic radiosurgery (SFSR) for lung tumors," which demonstrated the safety and feasibility of delivering high-dose, single-fraction radiation to lung lesions—a novel approach at the time. This work laid the groundwork for modern SBRT protocols, transforming treatment paradigms for early-stage lung cancer patients who are not surgical candidates. While his seminal paper has garnered over 700 citations, reflecting its enduring influence on clinical practice and subsequent research, Ho’s broader impact is seen in the widespread adoption of SBRT worldwide. His achievements include advancing precision radiotherapy techniques that minimize damage to healthy tissue while maximizing tumor control, significantly improving patient outcomes and quality of life.
Research Focus
Key Achievements
Top Papers
- 1